Results 81 to 90 of about 14,145 (218)

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. [PDF]

Am J Epidemiol, 2022
Prunas O, Weinberger DM, Medini D, Tizzoni M, Argante L.   +4 more
europepmc   +1 more source

Meningococcal conjugate vaccines: optimizing global impact

Infection and Drug Resistance, 2011
Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, 2Meningitis and Vaccine Preventable Diseases Branch, National Center for ...
Terranella A, Cohn A, Clark T
doaj  

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease

Expert Review of Vaccines
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde, Chiranjiwi Bhusal, Catherine A. Cosgrove, Woo-Yun Sohn   +3 more
doaj   +1 more source

Impact of meningococcal group B OMV vaccines, beyond their brief

Human Vaccines & Immunotherapeutics, 2018
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity.
Helen Petousis-Harris
doaj   +1 more source

Change in Recommendation for Meningococcal Vaccine for Travelers [PDF]

, 1999

openalex   +1 more source

Meningococcal vaccine and herd immunity [PDF]

, 1999
Stelios Sbyrakis, Emmanouil Galanakis
openalex   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

Journal of Immunology Research, 2015
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini, D. Panatto, N. L. Bragazzi, P. L. Lai, A. Bechini, M. Levi, P. Durando, D. Amicizia   +7 more
doaj   +1 more source

Meningococcal vaccine in sub-Saharan Africa [PDF]

, 1997
JH Higham
openalex   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source